JP2002513771A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2002513771A5 JP2002513771A5 JP2000546796A JP2000546796A JP2002513771A5 JP 2002513771 A5 JP2002513771 A5 JP 2002513771A5 JP 2000546796 A JP2000546796 A JP 2000546796A JP 2000546796 A JP2000546796 A JP 2000546796A JP 2002513771 A5 JP2002513771 A5 JP 2002513771A5
- Authority
- JP
- Japan
- Prior art keywords
- aqueous vaccine
- hav
- vaccine preparation
- hbsag
- children
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 241000709721 Hepatovirus A Species 0.000 description 8
- 238000009472 formulation Methods 0.000 description 4
- 239000000203 mixture Substances 0.000 description 4
- 229960005486 vaccine Drugs 0.000 description 4
- WSFSSNUMVMOOMR-UHFFFAOYSA-N Formaldehyde Chemical compound O=C WSFSSNUMVMOOMR-UHFFFAOYSA-N 0.000 description 3
- WNROFYMDJYEPJX-UHFFFAOYSA-K aluminium hydroxide Chemical compound [OH-].[OH-].[OH-].[Al+3] WNROFYMDJYEPJX-UHFFFAOYSA-K 0.000 description 3
- 239000000427 antigen Substances 0.000 description 3
- 102000036639 antigens Human genes 0.000 description 3
- 108091007433 antigens Proteins 0.000 description 3
- 229960004279 formaldehyde Drugs 0.000 description 3
- 235000019256 formaldehyde Nutrition 0.000 description 3
- 229940088597 hormone Drugs 0.000 description 3
- 239000005556 hormone Substances 0.000 description 3
- 238000000034 method Methods 0.000 description 3
- AZDRQVAHHNSJOQ-UHFFFAOYSA-N alumane Chemical class [AlH3] AZDRQVAHHNSJOQ-UHFFFAOYSA-N 0.000 description 2
- ILRRQNADMUWWFW-UHFFFAOYSA-K aluminium phosphate Chemical compound O1[Al]2OP1(=O)O2 ILRRQNADMUWWFW-UHFFFAOYSA-K 0.000 description 2
- 208000002672 hepatitis B Diseases 0.000 description 2
- 101710137302 Surface antigen S Proteins 0.000 description 1
- 208000005252 hepatitis A Diseases 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB9809507.8 | 1998-05-01 | ||
| GBGB9809507.8A GB9809507D0 (en) | 1998-05-01 | 1998-05-01 | Novel composition |
| PCT/EP1999/003024 WO1999056772A2 (en) | 1998-05-01 | 1999-04-27 | Hepatitis vaccine |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2010148061A Division JP2010209118A (ja) | 1998-05-01 | 2010-06-29 | 新規組成物 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2002513771A JP2002513771A (ja) | 2002-05-14 |
| JP2002513771A5 true JP2002513771A5 (enExample) | 2006-04-20 |
| JP5138843B2 JP5138843B2 (ja) | 2013-02-06 |
Family
ID=10831426
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2000546796A Expired - Lifetime JP5138843B2 (ja) | 1998-05-01 | 1999-04-27 | 新規組成物 |
| JP2010148061A Pending JP2010209118A (ja) | 1998-05-01 | 2010-06-29 | 新規組成物 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2010148061A Pending JP2010209118A (ja) | 1998-05-01 | 2010-06-29 | 新規組成物 |
Country Status (28)
| Country | Link |
|---|---|
| EP (1) | EP1073462B1 (enExample) |
| JP (2) | JP5138843B2 (enExample) |
| KR (1) | KR100612547B1 (enExample) |
| CN (1) | CN1263509C (enExample) |
| AR (1) | AR016987A1 (enExample) |
| AT (1) | ATE345815T1 (enExample) |
| AU (1) | AU743759B2 (enExample) |
| BR (1) | BR9910157A (enExample) |
| CA (1) | CA2331086C (enExample) |
| CO (1) | CO5050367A1 (enExample) |
| CY (1) | CY1107322T1 (enExample) |
| CZ (1) | CZ301232B6 (enExample) |
| DE (1) | DE69934108T2 (enExample) |
| DK (1) | DK1073462T3 (enExample) |
| ES (1) | ES2277437T3 (enExample) |
| GB (1) | GB9809507D0 (enExample) |
| GC (1) | GC0000101A (enExample) |
| HU (1) | HU228209B1 (enExample) |
| IL (1) | IL139269A0 (enExample) |
| MY (1) | MY128929A (enExample) |
| NO (1) | NO20005483L (enExample) |
| NZ (1) | NZ507902A (enExample) |
| PL (1) | PL190729B1 (enExample) |
| PT (1) | PT1073462E (enExample) |
| TR (1) | TR200003235T2 (enExample) |
| TW (1) | TW553744B (enExample) |
| WO (1) | WO1999056772A2 (enExample) |
| ZA (1) | ZA200006118B (enExample) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1513555A (zh) * | 2003-07-31 | 2004-07-21 | 长春生物制品研究所 | 甲-乙型肝炎联合疫苗及其冻干制剂 |
| EP1862176A1 (de) * | 2006-05-31 | 2007-12-05 | Rhein Biotech Gesellschaft für neue biotechnologische Prozesse und Produkte mbH | Ein Verfahren zur Herstellung einer Impfzusammensetzung |
| EP1862177A1 (de) * | 2006-06-01 | 2007-12-05 | Rhein Biotech Gesellschaft für neue biotechnologische Prozesse und Produkte mbH | Ein Verfahren zur Herstellung einer Impfzusammensetzung |
| CN102198270B (zh) * | 2011-05-16 | 2012-06-27 | 大连汉信生物制药有限公司 | 一种含铝佐剂乙肝疫苗的制备方法 |
| KR101281098B1 (ko) * | 2011-06-30 | 2013-07-02 | 주식회사 녹십자 | Ｂ형 간염 바이러스 표면 항원상의 에피토프 및 이의 용도 |
| CN102988975A (zh) * | 2012-11-30 | 2013-03-27 | 深圳康泰生物制品股份有限公司 | 甲型、乙型肝炎联合疫苗及其制备方法 |
| US9849066B2 (en) | 2013-04-24 | 2017-12-26 | Corning Incorporated | Delamination resistant pharmaceutical glass containers containing active pharmaceutical ingredients |
| IL283039B2 (en) * | 2018-11-13 | 2025-01-01 | Variation Biotechnologies Inc | Immunological preparations for the treatment of hepatitis B |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH0349686A (ja) * | 1989-07-11 | 1991-03-04 | Smithkline Biologicals Sa | レトロウイルスｇａｇ蛋白の真核生物細胞における発現 |
| DE122010000016I1 (de) * | 1992-05-23 | 2010-07-08 | Glaxosmithkline Biolog Sa | Kombinierte Impfstoffe, die Hepatitis-B-Oberflächen antigen und andere Antigene enthalten |
| GB9503863D0 (en) * | 1995-02-25 | 1995-04-19 | Smithkline Beecham Biolog | Vaccine compositions |
| DE69731357T2 (de) * | 1996-03-23 | 2006-02-02 | The Research Foundation For Microbial Diseases Of Osaka University, Suita | Funktionelles antigenfragment von tetanustoxin und tetanusvakzine |
-
1998
- 1998-05-01 GB GBGB9809507.8A patent/GB9809507D0/en not_active Ceased
-
1999
- 1999-04-27 GC GCP1999139 patent/GC0000101A/xx active
- 1999-04-27 AU AU41379/99A patent/AU743759B2/en not_active Expired
- 1999-04-27 WO PCT/EP1999/003024 patent/WO1999056772A2/en not_active Ceased
- 1999-04-27 PL PL99344137A patent/PL190729B1/pl unknown
- 1999-04-27 JP JP2000546796A patent/JP5138843B2/ja not_active Expired - Lifetime
- 1999-04-27 AT AT99924871T patent/ATE345815T1/de active
- 1999-04-27 KR KR1020007012162A patent/KR100612547B1/ko not_active Expired - Lifetime
- 1999-04-27 CZ CZ20004061A patent/CZ301232B6/cs not_active IP Right Cessation
- 1999-04-27 CA CA2331086A patent/CA2331086C/en not_active Expired - Lifetime
- 1999-04-27 NZ NZ507902A patent/NZ507902A/en unknown
- 1999-04-27 TR TR2000/03235T patent/TR200003235T2/xx unknown
- 1999-04-27 BR BR9910157-2A patent/BR9910157A/pt not_active Application Discontinuation
- 1999-04-27 DK DK99924871T patent/DK1073462T3/da active
- 1999-04-27 HU HU0101652A patent/HU228209B1/hu unknown
- 1999-04-27 DE DE69934108T patent/DE69934108T2/de not_active Expired - Lifetime
- 1999-04-27 IL IL13926999A patent/IL139269A0/xx not_active IP Right Cessation
- 1999-04-27 CN CNB998081418A patent/CN1263509C/zh not_active Expired - Lifetime
- 1999-04-27 ES ES99924871T patent/ES2277437T3/es not_active Expired - Lifetime
- 1999-04-27 EP EP99924871A patent/EP1073462B1/en not_active Expired - Lifetime
- 1999-04-27 PT PT99924871T patent/PT1073462E/pt unknown
- 1999-04-29 AR ARP990102002A patent/AR016987A1/es unknown
- 1999-04-29 MY MYPI99001705A patent/MY128929A/en unknown
- 1999-04-29 CO CO99025940A patent/CO5050367A1/es unknown
- 1999-06-29 TW TW088110991A patent/TW553744B/zh not_active IP Right Cessation
-
2000
- 2000-10-30 ZA ZA200006118A patent/ZA200006118B/xx unknown
- 2000-10-31 NO NO20005483A patent/NO20005483L/no not_active Application Discontinuation
-
2007
- 2007-02-08 CY CY20071100163T patent/CY1107322T1/el unknown
-
2010
- 2010-06-29 JP JP2010148061A patent/JP2010209118A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| KR100287083B1 (ko) | B형 간염 표면 항원 및 다른 항원을 포함하는 조합 백신 | |
| JP2007186524A (ja) | 多糖類抗原−キャリア蛋白接合体および遊離キャリア蛋白を有してなるワクチン | |
| JP2003526662A5 (enExample) | ||
| JP2001503422A (ja) | ジフテリア―及び破傷風毒素による無細胞百日咳ワクチン | |
| JP2002513771A5 (enExample) | ||
| JP2010209118A (ja) | 新規組成物 | |
| Krishnan et al. | Efficacy of inactivated poliovirus vaccine in India | |
| JP2002534438A (ja) | 新規治療法 | |
| SMEGO JR et al. | The case for routine hepatitis B immunization in infancy for populations at increased risk | |
| US7144703B2 (en) | Composition | |
| RU2130779C1 (ru) | Комбинированная вакцина для иммунопрофилактики вирусного гепатита в, столбняка и дифтерии | |
| Wiström et al. | Antibody response after intradermal administration of recombinant hepatitis B vaccine in children | |
| Son | Infectious diseases recently causing vaccination problems: Chickenpox, Measles, and Hepatitis B | |
| HK1034202B (en) | Combined vaccine against hepatitis a and hepatitis b | |
| McMahon et al. | Protective Efficacy of Hepatitis B | |
| Krugman | Recollections of a Hepatitis Investigator—1940–1993 | |
| PL174077B1 (pl) | Szczepionka do ochrony przed zakażeniem lub leczeniem zakażeń Hepatitis B i heterologicznych chorób, zawierająca antygen powierzchniowy Hepatitis B (HBsAg) | |
| HK1147950A (en) | Combined vaccines comprising hepatitis b surface antigen and other antigens | |
| HK1137937A (en) | Combined vaccines comprising hepatitis b surface antigen and other antigens | |
| RU95120086A (ru) | Вакцинная композиция, способ ее получения, 3-0-дезацилированный монофосфориллипид а, способ получения его раствора, применение, способ лечения |